Diabetes

Researchers at the Department of Clinical Medicine at the University of Bergen (UiB) have discovered that medical treatment against diabetes reduces the risk of getting Parkinson´s disease by 35 per cent.

By removing the protein galectin-3 (Gal3), a team of investigators led by University of California School of Medicine researchers were able to reverse diabetic insulin resistance and glucose intolerance in mouse models of obesity and diabetes.

B12 deficiency during pregnancy may predispose children to metabolic problems such as type-2 diabetes, according to research presented today at the Society for Endocrinology's annual Conference in Brighton. These findings could lead to a review of current vitamin B12 requirements for pregnant women, whether through an improved diet or supplements.

Sanofi  and Verily Life Sciences LLC, (formerly Google Life Sciences), an Alphabet company, today announced the launch of Onduo, a joint venture created through Sanofi and Verily’s diabetes-focused collaboration. The joint venture is based in Kendall Square in Cambridge.  Onduo’s mission is to help people with diabetes live full, healthy lives by developing comprehensive solutions that combine devices, software, medicine, and professional care to enable simple and intelligent disease management.

Use of Metformin commonly used as the front-line treatment for type 2 diabetes improves survival for some breast cancer patients, and shows promise as a treatment for patients diagnosed with endometrial hyperplasia, according to the results of two new studies presented by researchers from the Perelman School of Medicine at the University of Pennsylvania at the American Society of Clinical Oncology (ASCO) Annual Meeting.

With Diabetes being the theme for World Health Day this year, health experts have said that only 10 percent of Indians were aware that diabetes in its later stages damages blood vessels of the eyes, heart, nerves, feet and kidneys.

An injectable drug widely used for the treatment of type 2 diabetes along with controlled diet and proper exercise plan is likely to lead to major health improvements, suggests a new research.

People with type 1 diabetes are three times more prone to the risk of developing epilepsy later in life, finds a new research.The findings revealed that in patients with type 1 diabetes, the risk of developing epilepsy a neurological disorder was significantly higher than that in patients without the disease.

A drug used in the treatment of diabetes can increase the risk of bladder cancer, warns a new study adding that the risk increases with the rising duration of use and the dose.